Table 1 Demographic and clinical data of the study population
From: Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder
|  | OCD patients (N = 102) | Controls (N = 47) | Statistic | p value |
|---|---|---|---|---|
Male gender, N (%) | 52 (51.0) | 14 (29.8) | χ 2 = 5.86 | 0.016a |
Age (mean ± SEM) | 14.78 ± 0.26 | 16.29 ± 0.26 | t = − 3.608 | 0.0004b |
Age of onset (mean ± SEM) | 12.95 ± 0.28 | – | – | – |
Duration of illness, months (mean ± SEM) | 24.62 ± 2.44 | – | – | – |
CY-BOCS score (mean ± SEM) | 25.97 ± 0.64 | – | – | – |
Comorbidities, N (%) | ||||
 Anxiety or mood disorders | 46 (45.1) | – | – | – |
 ADHD or tic disorder | 22 (21.6) | – | – | – |
Treatment, N (%) | ||||
 Medicated | 82 (80.4) | – | – | – |
 Antidepressants | 59 (72) | – | – | – |
 Antipsychotics | 1 (1.2) | – | – | – |
 Antidepressants + antipsychotics | 22 (26.8) | – | – | – |
 Non-medicated | 20 (19.6) | – | – | – |